THU0637-HPR THE ASSOCIATION BETWEEN THE RECALL PERIOD AND THE AMOUNT OF INFORMATION ABOUT REPORTED ADVERSE DRUG REACTIONS BY PATIENTS USING BIOLOGICALS

Background: In order to monitor the safety of medicines pharmacovigilance, it is important that patients report their adverse drug reactions (ADRs). Theoretically, the quality of the reported information might be affected by the elapsed time between the onset of the ADR and the moment of reporting. Real-life evidence demonstrating a negative relationship between this recall period and the quality of reported ADRs is however lacking. Objectives:...